Currently, Dr Dobaño is the head of the Malaria Immunology Group at the Barcelona Institute for Global Health (ISGlobal) and also conducts her research at the Manhiça Health Research Centre (CISM). She did her MSc on Applied Molecular Biology of Infectious Diseases at the London School of Hygiene and Tropical Medicine. In 1999 she obtained her PhD degree on Malaria Immunology at the University of Edinburgh, Scotland, funded by a studentship from the Wellcome Trust, with field work developed at the Malaria Project and Wellcome Trust Centre, Blantyre, Malawi.
In 2003 Dr Dobaño joined the Barcelona Centre for International Health Research (CRESIB, merged to ISGlobal in 2015) and currently develop her research as Associate Research Professor. Dr Dobaño coordinates large multicenter studies on immunity to malaria vaccine candidates and immune responses to Plasmodium parasites in vulnerable populations. She has more than 72 peer reviewed publications in major international journals, 37 seven within journals with a Q impact factor 1. Her publications have been cited at least 1,274 times (including self-citations).
Specific areas of study include:
• Immunity to the RTS,S malaria vaccine candidate
• Biomarkers of immunity and susceptibility to malaria in individuals exposed to Plasmodium infection, including immuno-pathological markers of severe malaria and placental malaria
• Innate immune responses to malaria in early infancy
• Impact of malaria control tools (intermittent preventive treatment, indoor residual spraying) in the development of naturally-acquired immunity
• Development of multi-parameter and functional immunological assays